Vera Therapeutics VERA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$9.63M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 34.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 23.33% to 16.85% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Deutsche Asset & Wealth Management | Mutual Fund | 2026/Q3 | +1,029,770 | 2.9% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +589,831 | 2.5% |
| Putnam LLC | Mutual Fund | 2026/Q3 | +291,747 | 0.4% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +268,948 | 1.0% |
| Rhenman & Partners Asset Management AB | Hedge Fund | 2026/Q3 | +242,500 | 0.3% |
| Davern Capital Partners, LP | Hedge Fund | 2026/Q3 | +129,442 | 0.9% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +122,610 | 0.9% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +100,461 | 0.8% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +85,852 | 1.3% |
| Morgan Stanley | Public Company | 2026/Q3 | +2,425,794 | 3.8% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +2,200,000 | 3.0% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +785,148 | 5.8% |
| Frontier Capital Management | Mutual Fund | 2026/Q3 | +743,912 | 1.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +659,658 | 8.0% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +615,039 | 1.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Marshall Fordyce | Chief Executive Officer | Derivative Exercise and Sale | -18,500 | $37.00 | 288,537 |
| 10 Sep 2026 | Joseph Young | Senior VP of Finance & Chief Accounting Officer | Derivative Exercise and Retained | +5,000 | $3.94 | 51,761 |
| 1 Sep 2026 | Marshall Fordyce | Chief Executive Officer | Derivative Exercise and Sale | -18,500 | $35.12 | 288,537 |
| 2 Aug 2026 | Nancy Boman | Other Acquisition | +44,987 | – | 44,987 | |
| 2 Aug 2026 | Nancy Boman | Other Derivative Acquisition | +63,011 | $32.23 | 63,011 | |
| 6 Jul 2026 | Marshall Fordyce | Chief Executive Officer | Derivative Exercise and Sale | -46,250 | $43.59 | 288,537 |
| 22 Jun 2026 | Marshall Fordyce | Chief Executive Officer | Derivative Exercise and Sale | -18,500 | $38.43 | 288,537 |
| 20 May 2026 | Michael Morrissey | Independent Chairperson | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | Patrick Gerald Enright | Independent Director | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | Beth Seidenberg | Independent Director | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | Scott William Morrison | Independent Director | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | James Meyers | Independent Director | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | Andrew Cheng | Independent Director | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | Christy Oliger | Independent Director | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 |
| 20 May 2026 | Kimball Hall | Other Derivative Acquisition | +17,084 | $34.35 | 17,084 | |
| 11 May 2026 | Marshall Fordyce | Chief Executive Officer | Derivative Exercise and Sale | -18,500 | $37.09 | 288,537 |
| 13 Apr 2026 | Marshall Fordyce | Chief Executive Officer | Automatic Disposition | -22,951 | $45.51 | 288,537 |
| 22 Mar 2026 | Jane Wright-Mitchell | Chief Legal Officer | Other Acquisition | +42,403 | – | 42,403 |
| 22 Mar 2026 | Jane Wright-Mitchell | Chief Legal Officer | Other Derivative Acquisition | +56,850 | $40.73 | 56,850 |
| 12 Mar 2026 | Joseph Young | Senior VP of Finance & Chief Accounting Officer | Derivative Exercise and Retained | +10,000 | $3.94 | 46,761 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 12,141,556 | 16.8% | 8.5 |
| 15 Oct 2026 | 13,587,185 | 18.9% | 7.2 |
| 30 Sep 2026 | 17,240,397 | 23.9% | 7.8 |
| 15 Sep 2026 | 17,035,040 | 23.6% | 6.2 |
| 31 Aug 2026 | 19,873,297 | 27.6% | 10.8 |
| 14 Aug 2026 | 16,814,429 | 23.3% | 7.0 |
No comments yet — be the first to weigh in on VERA.
Sign in to join the discussion.